Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67


Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior.

Li Y, Yin A, Sun X, Zhang M, Zhang J, Wang P, Xie R, Li W, Fan Z, Zhu Y, Wang H, Dong H, Wu S, Xiong L.

J Clin Invest. 2017 Dec 1;127(12):4270-4284. doi: 10.1172/JCI94455. Epub 2017 Oct 23.


How French media have portrayed ADHD to the lay public and to social workers.

Ponnou S, Gonon F.

Int J Qual Stud Health Well-being. 2017 Jun;12(sup1):1298244. doi: 10.1080/17482631.2017.1298244.


Poor replication validity of biomedical association studies reported by newspapers.

Dumas-Mallet E, Smith A, Boraud T, Gonon F.

PLoS One. 2017 Feb 21;12(2):e0172650. doi: 10.1371/journal.pone.0172650. eCollection 2017.


An integrated feature ranking and selection framework for ADHD characterization.

Xiao C, Bledsoe J, Wang S, Chaovalitwongse WA, Mehta S, Semrud-Clikeman M, Grabowski T.

Brain Inform. 2016 Sep;3(3):145-155. Epub 2016 Apr 2.


Gamification of Cognitive Assessment and Cognitive Training: A Systematic Review of Applications and Efficacy.

Lumsden J, Edwards EA, Lawrence NS, Coyle D, Munafò MR.

JMIR Serious Games. 2016 Jul 15;4(2):e11. doi: 10.2196/games.5888.


A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue.

Elsayed M, Magistretti PJ.

Front Cell Neurosci. 2015 Dec 16;9:468. doi: 10.3389/fncel.2015.00468. eCollection 2015. Review.


Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE.

Pharmacol Rev. 2015 Oct;67(4):1005-24. doi: 10.1124/pr.114.010397. Review.


Decision making: effects of methylphenidate on temporal discounting in nonhuman primates.

Rajala AZ, Jenison RL, Populin LC.

J Neurophysiol. 2015 Jul;114(1):70-9. doi: 10.1152/jn.00278.2015. Epub 2015 May 13.


Acute oral administration of low doses of methylphenidate targets calretinin neurons in the rat septal area.

García-Avilés Á, Albert-Gascó H, Arnal-Vicente I, Elhajj E, Sanjuan-Arias J, Sanchez-Perez AM, Olucha-Bordonau F.

Front Neuroanat. 2015 Mar 23;9:33. doi: 10.3389/fnana.2015.00033. eCollection 2015.


Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior.

Huang J, Zhong Z, Wang M, Chen X, Tan Y, Zhang S, He W, He X, Huang G, Lu H, Wu P, Che Y, Yan YL, Postlethwait JH, Chen W, Wang H.

J Neurosci. 2015 Feb 11;35(6):2572-87. doi: 10.1523/JNEUROSCI.2551-14.2015.


The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.

Vanicek T, Spies M, Rami-Mark C, Savli M, Höflich A, Kranz GS, Hahn A, Kutzelnigg A, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Volkow ND, Kasper S, Lanzenberger R.

JAMA Psychiatry. 2014 Dec 1;71(12):1340-1349. doi: 10.1001/jamapsychiatry.2014.1226.


Dopamine transporter gene susceptibility to methylation is associated with impulsivity in nonhuman primates.

Rajala AZ, Zaitoun I, Henriques JB, Converse AK, Murali D, Epstein ML, Populin LC.

J Neurophysiol. 2014 Nov 1;112(9):2138-46. doi: 10.1152/jn.00534.2014. Epub 2014 Aug 13.


Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.

Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A.

Addiction. 2014 Sep;109(9):1489-500. doi: 10.1111/add.12608. Epub 2014 Jul 8.


Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD.

Neurochem Int. 2014 Jul;73:56-70. doi: 10.1016/j.neuint.2013.11.009. Epub 2013 Dec 8. Review.


Smoking behaviour and mental health disorders--mutual influences and implications for therapy.

Minichino A, Bersani FS, Calò WK, Spagnoli F, Francesconi M, Vicinanza R, Delle Chiaie R, Biondi M.

Int J Environ Res Public Health. 2013 Oct 10;10(10):4790-811. doi: 10.3390/ijerph10104790. Review.


Increased locomotor activity and non-selective attention and impaired learning ability in SD rats after lentiviral vector-mediated RNA interference of Homer 1a in the brain.

Hong Q, Yang L, Zhang M, Pan XQ, Guo M, Fei L, Tong ML, Chen RH, Guo XR, Chi X.

Int J Med Sci. 2013;10(1):90-102. doi: 10.7150/ijms.4892. Epub 2012 Dec 27.


Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.

Spencer TJ, Biederman J, Faraone SV, Madras BK, Bonab AA, Dougherty DD, Batchelder H, Clarke A, Fischman AJ.

Biol Psychiatry. 2013 Jul 15;74(2):84-9. doi: 10.1016/j.biopsych.2012.11.010. Epub 2012 Dec 27.


DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.

Turic D, Swanson J, Sonuga-Barke E.

Pharmgenomics Pers Med. 2010;3:61-78. Epub 2010 May 21.


Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice.

Adriani W, Koot S, Columba-Cabezas S, Romano E, Travaglini D, van den Bos R, Granstrem O, Ali SF, Laviola G.

Behav Brain Funct. 2012 Nov 28;8:54. doi: 10.1186/1744-9081-8-54.

Supplemental Content

Support Center